Naschitz Brandes Amir Represented both Israeli Biotech Fund and aMoon II Fund in a $13.6 million Financing Round of Ayala Pharmaceuticals Inc., a biopharmaceutical company dedicated to developing targeted cancer therapies.

Israel Biotech Fund was represented by partner Anat Igner and aMoon II Fund was represented by partner Inbar Mishori Bartal.